Stock KRYS KRYSTAL BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Krystal Biotech, Inc.

Equities

KRYS

US5011471027

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
156.9 USD +0.77% Intraday chart for Krystal Biotech, Inc. -1.04% +26.45%
04-22 Krystal Biotech, Inc Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung CI
04-16 Stifel Adjusts Price Target on Krystal Biotech to $204 From $178, Maintains Buy Rating MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024
AQ
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
AQ
Krystal Biotech, Inc Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
CI
Stifel Adjusts Price Target on Krystal Biotech to $204 From $178, Maintains Buy Rating
MT
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
AQ
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
AQ
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing
MT
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing
MT
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference
AQ
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference
AQ
Sector Update: Health Care Stocks Ease Late Afternoon
MT
Sector Update: Health Care Stocks Weaker Monday Afternoon
MT
Top Midday Gainers
MT
Krystal Biotech Shares Jump After Surprise Q4 Profit
MT
Krystal Biotech Swings to Q4 Profit as Company Generates Revenue; Shares Climb Pre-Bell
MT
Transcript : Krystal Biotech, Inc., Q4 2023 Earnings Call, Feb 26, 2024
Krystal Biotech, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Earnings Flash (KRYS) KRYSTAL BIOTECH Posts Q4 EPS $0.30, vs. Street Est of $-0.25
MT
Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
AQ
Krystal Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KRYS Stock
  4. News Krystal Biotech, Inc.